Among all patients, aged between 20 and 80 years old, with heart failure (HF) underwent guideline-directed medical therapy (GDMT) in a tertiary care hospital, 40 of them with stable clinical status greater than 4 weeks were sequentially enrolled in the study. Thery were further allocated into the high-intensity interval training (HIIT) and GDMT groups. The 20 HIIT participants underwent additional 36 sessions of exercise training with alternating 80% of peak oxygen consumption (VO2peak) and 40% of VO2peak for 30 mins, whereas the remaining 20 GDMT participants received regular medication treatement. Baseline clinical information was recorded. Cardiopulmonary exercise test (CPET), 2-D echocardiography, bioimpedance analysis, questionnaire for quality of life, serum b-type natriuretic peptide (BNP), circulating microRNA (miRNA) profile and serum metabolomics before intervention were assessed. Cardiomyocytes and/or cardiac fibroblasts were harvested in 10% patient serum for cell activities, western blot, and messenger RNA studies. All the above examinations were followed after completing the exercise training in HIIT participants and 3-4 months after initial visit in GDMT participants. Parametric anslysis was used to assess the differences of continuous parameters with normal distributions. Those without normal distributions were estimated with non-parametric analysis. 2x2 ANOVA was conducted to compare differences of the circulating miRNA between the two groups of participants before and after interventions. Non-continous parameters between the two groups were assessed by chi-square test.
Age range
20 Years – 80 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Peak oxygen consumption (VO2peak)
Timeframe: 4 months
Oxygen uptake efficiency slope (OUES)
Timeframe: 4 months
minute ventilation to minute CO2 ventilation slope (Ve-VCO2)
Timeframe: 4 months
Heart rate reserve (HRR)
Timeframe: 4 months
Left ventricular ejection fraction (LVEF)
Timeframe: 4 months
Left ventricle end-diastolic volume (LVEDV)
Timeframe: 4 months
Left ventricle end-systolic volume (LVESV)
Timeframe: 4 months
Left ventricle mass (LVM)
Timeframe: 4 months
Left ventricle mass index (LVMI)
Timeframe: 4 months
early diastolic mitral inflow velocity-to-early diastolic mitral annular tissue velocity ratio (E/e')
Timeframe: 4 months
b-type natriuretic peptide (BNP)
Timeframe: 4 months
Appendicular skeletal muscle index (ASMI)
Timeframe: 4 months
skeletal muscle mass (SMM)
Timeframe: 4 months
body fat mass (BFM)
Timeframe: 4 months
Physical component score (PCS)
Timeframe: 4 months
Mental component score (MCS)
Timeframe: 4 months